HEADER TRANSFERASE/TRANSFERASE INHIBITOR 30-AUG-13 4MIC TITLE CRYSTAL STRUCTURE OF GPB IN COMPLEX WITH SUGAR (N-{(2E)-3-[4-(PROPAN- TITLE 2 2-YL)PHENYL]PROP-2-ENOYL}-BETA-D-GLUCOPYRANOSYLAMINE) (S6) CAVEAT 4MIC SEVERAL PEPTIDE BONDS ARE NOT PROPERLY LINKED COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOPHOSPHORYLASE; COMPND 5 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: EUROPEAN RABBIT,JAPANESE WHITE RABBIT,DOMESTIC SOURCE 4 RABBIT,RABBITS; SOURCE 5 ORGANISM_TAXID: 9986; SOURCE 6 OTHER_DETAILS: MUSCLE KEYWDS ALPHA AND BETA PROTEIN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.L.KANTSADI,D.S.M.CHATZILEONTIADOU,D.D.LEONIDAS REVDAT 6 06-DEC-23 4MIC 1 REMARK REVDAT 5 20-SEP-23 4MIC 1 REMARK LINK REVDAT 4 15-NOV-17 4MIC 1 REMARK REVDAT 3 15-OCT-14 4MIC 1 AUTHOR REVDAT 2 10-SEP-14 4MIC 1 JRNL REVDAT 1 23-JUL-14 4MIC 0 JRNL AUTH V.PARMENOPOULOU,A.L.KANTSADI,V.G.TSIRKONE, JRNL AUTH 2 D.S.CHATZILEONTIADOU,S.MANTA,S.E.ZOGRAPHOS,C.MOLFETA, JRNL AUTH 3 G.ARCHONTIS,L.AGIUS,J.M.HAYES,D.D.LEONIDAS,D.KOMIOTIS JRNL TITL STRUCTURE BASED INHIBITOR DESIGN TARGETING GLYCOGEN JRNL TITL 2 PHOSPHORYLASE B. VIRTUAL SCREENING, SYNTHESIS, BIOCHEMICAL JRNL TITL 3 AND BIOLOGICAL ASSESSMENT OF NOVEL JRNL TITL 4 N-ACYL-BETA-D-GLUCOPYRANOSYLAMINES. JRNL REF BIOORG.MED.CHEM. V. 22 4810 2014 JRNL REFN ISSN 0968-0896 JRNL PMID 25092521 JRNL DOI 10.1016/J.BMC.2014.06.058 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 3 NUMBER OF REFLECTIONS : 31316 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1646 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.51 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2400 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.01 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE SET COUNT : 135 REMARK 3 BIN FREE R VALUE : 0.2710 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6577 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.42 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.72000 REMARK 3 B22 (A**2) : 0.72000 REMARK 3 B33 (A**2) : -1.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.596 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.280 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.176 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.792 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6767 ; 0.005 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 6466 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9163 ; 0.981 ; 1.957 REMARK 3 BOND ANGLES OTHERS (DEGREES): 14810 ; 0.740 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 806 ; 5.393 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 347 ;34.868 ;23.545 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1172 ;15.392 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 59 ;17.800 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 991 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7662 ; 0.003 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1648 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4MIC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000081946. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : SEALED TUBE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : OXFORD DIFFRACTION ENHANCE ULTRA REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5419 REMARK 200 MONOCHROMATOR : CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : AGILENT ATLAS CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSALISPRO REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33056 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 18.230 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.4 REMARK 200 DATA REDUNDANCY : 2.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09900 REMARK 200 FOR THE DATA SET : 6.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.53100 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 3SYM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10 MM BES BUFFER, PH 6.7, SMALL TUBES, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.35500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.37000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.37000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.53250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.37000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.37000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 29.17750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.37000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.37000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.53250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.37000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.37000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 29.17750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 58.35500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 57230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 116.71000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE A 252 REMARK 465 ASN A 253 REMARK 465 LEU A 254 REMARK 465 LYS A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 GLY A 260 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 VAL A 322 REMARK 465 ARG A 323 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 1048 O HOH A 1101 2.11 REMARK 500 O HOH A 1101 O HOH A 1109 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 19 70.93 -118.42 REMARK 500 LEU A 131 41.43 -87.82 REMARK 500 TYR A 203 -135.43 60.59 REMARK 500 GLN A 211 42.16 -87.58 REMARK 500 ASN A 236 15.05 58.87 REMARK 500 SER A 313 50.83 -105.17 REMARK 500 ASP A 339 -166.88 66.57 REMARK 500 THR A 466 -80.59 -120.93 REMARK 500 LEU A 492 -67.92 -142.03 REMARK 500 ASP A 514 80.94 -158.79 REMARK 500 LYS A 568 166.14 171.82 REMARK 500 SER A 674 -57.74 -139.71 REMARK 500 THR A 676 -30.34 -136.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 26Y A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4MHO RELATED DB: PDB REMARK 900 RELATED ID: 4MHS RELATED DB: PDB REMARK 900 RELATED ID: 4MI3 RELATED DB: PDB REMARK 900 RELATED ID: 4MI6 RELATED DB: PDB REMARK 900 RELATED ID: 4MI9 RELATED DB: PDB DBREF 4MIC A 12 836 UNP P00489 PYGM_RABIT 13 837 SEQRES 1 A 825 GLN ILE SER VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL SEQRES 2 A 825 THR GLU LEU LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE SEQRES 3 A 825 THR LEU VAL LYS ASP ARG ASN VAL ALA THR PRO ARG ASP SEQRES 4 A 825 TYR TYR PHE ALA LEU ALA HIS THR VAL ARG ASP HIS LEU SEQRES 5 A 825 VAL GLY ARG TRP ILE ARG THR GLN GLN HIS TYR TYR GLU SEQRES 6 A 825 LYS ASP PRO LYS ARG ILE TYR TYR LEU SER LEU GLU PHE SEQRES 7 A 825 TYR MET GLY ARG THR LEU GLN ASN THR MET VAL ASN LEU SEQRES 8 A 825 ALA LEU GLU ASN ALA CYS ASP GLU ALA THR TYR GLN LEU SEQRES 9 A 825 GLY LEU ASP MET GLU GLU LEU GLU GLU ILE GLU GLU ASP SEQRES 10 A 825 ALA GLY LEU GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA SEQRES 11 A 825 CYS PHE LEU ASP SER MET ALA THR LEU GLY LEU ALA ALA SEQRES 12 A 825 TYR GLY TYR GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN SEQRES 13 A 825 GLN LYS ILE CYS GLY GLY TRP GLN MET GLU GLU ALA ASP SEQRES 14 A 825 ASP TRP LEU ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG SEQRES 15 A 825 PRO GLU PHE THR LEU PRO VAL HIS PHE TYR GLY ARG VAL SEQRES 16 A 825 GLU HIS THR SER GLN GLY ALA LYS TRP VAL ASP THR GLN SEQRES 17 A 825 VAL VAL LEU ALA MET PRO TYR ASP THR PRO VAL PRO GLY SEQRES 18 A 825 TYR ARG ASN ASN VAL VAL ASN THR MET ARG LEU TRP SER SEQRES 19 A 825 ALA LYS ALA PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN SEQRES 20 A 825 VAL GLY GLY TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU SEQRES 21 A 825 ALA GLU ASN ILE SER ARG VAL LEU TYR PRO ASN ASP ASN SEQRES 22 A 825 PHE PHE GLU GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR SEQRES 23 A 825 PHE VAL VAL ALA ALA THR LEU GLN ASP ILE ILE ARG ARG SEQRES 24 A 825 PHE LYS SER SER LYS PHE GLY CYS ARG ASP PRO VAL ARG SEQRES 25 A 825 THR ASN PHE ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN SEQRES 26 A 825 LEU ASN ASP THR HIS PRO SER LEU ALA ILE PRO GLU LEU SEQRES 27 A 825 MET ARG VAL LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP SEQRES 28 A 825 LYS ALA TRP GLU VAL THR VAL LYS THR CYS ALA TYR THR SEQRES 29 A 825 ASN HIS THR VAL LEU PRO GLU ALA LEU GLU ARG TRP PRO SEQRES 30 A 825 VAL HIS LEU LEU GLU THR LEU LEU PRO ARG HIS LEU GLN SEQRES 31 A 825 ILE ILE TYR GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL SEQRES 32 A 825 ALA ALA ALA PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG SEQRES 33 A 825 MET SER LEU VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN SEQRES 34 A 825 MET ALA HIS LEU CYS ILE ALA GLY SER HIS ALA VAL ASN SEQRES 35 A 825 GLY VAL ALA ARG ILE HIS SER GLU ILE LEU LYS LYS THR SEQRES 36 A 825 ILE PHE LYS ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE SEQRES 37 A 825 GLN ASN LYS THR ASN GLY ILE THR PRO ARG ARG TRP LEU SEQRES 38 A 825 VAL LEU CYS ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU SEQRES 39 A 825 ARG ILE GLY GLU GLU TYR ILE SER ASP LEU ASP GLN LEU SEQRES 40 A 825 ARG LYS LEU LEU SER TYR VAL ASP ASP GLU ALA PHE ILE SEQRES 41 A 825 ARG ASP VAL ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS SEQRES 42 A 825 PHE ALA ALA TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE SEQRES 43 A 825 ASN PRO ASN SER LEU PHE ASP VAL GLN VAL LYS ARG ILE SEQRES 44 A 825 HIS GLU TYR LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL SEQRES 45 A 825 ILE THR LEU TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS SEQRES 46 A 825 PHE VAL VAL PRO ARG THR VAL MET ILE GLY GLY LYS ALA SEQRES 47 A 825 ALA PRO GLY TYR HIS MET ALA LYS MET ILE ILE LYS LEU SEQRES 48 A 825 ILE THR ALA ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL SEQRES 49 A 825 VAL GLY ASP ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR SEQRES 50 A 825 ARG VAL SER LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP SEQRES 51 A 825 LEU SER GLU GLN ILE SER THR ALA GLY THR GLU ALA SER SEQRES 52 A 825 GLY THR GLY ASN MET LLP PHE MET LEU ASN GLY ALA LEU SEQRES 53 A 825 THR ILE GLY THR MET ASP GLY ALA ASN VAL GLU MET ALA SEQRES 54 A 825 GLU GLU ALA GLY GLU GLU ASN PHE PHE ILE PHE GLY MET SEQRES 55 A 825 ARG VAL GLU ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR SEQRES 56 A 825 ASN ALA GLN GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG SEQRES 57 A 825 GLN ILE ILE GLU GLN LEU SER SER GLY PHE PHE SER PRO SEQRES 58 A 825 LYS GLN PRO ASP LEU PHE LYS ASP ILE VAL ASN MET LEU SEQRES 59 A 825 MET HIS HIS ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU SEQRES 60 A 825 GLU TYR VAL LYS CYS GLN GLU ARG VAL SER ALA LEU TYR SEQRES 61 A 825 LYS ASN PRO ARG GLU TRP THR ARG MET VAL ILE ARG ASN SEQRES 62 A 825 ILE ALA THR SER GLY LYS PHE SER SER ASP ARG THR ILE SEQRES 63 A 825 ALA GLN TYR ALA ARG GLU ILE TRP GLY VAL GLU PRO SER SEQRES 64 A 825 ARG GLN ARG LEU PRO ALA MODRES 4MIC LLP A 680 LYS HET LLP A 680 24 HET 26Y A 901 25 HETNAM LLP (2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5- HETNAM 2 LLP (PHOSPHONOOXYMETHYL)PYRIDIN-4- HETNAM 3 LLP YL]METHYLIDENEAMINO]HEXANOIC ACID HETNAM 26Y N-{(2E)-3-[4-(PROPAN-2-YL)PHENYL]PROP-2-ENOYL}-BETA-D- HETNAM 2 26Y GLUCOPYRANOSYLAMINE HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE FORMUL 1 LLP C14 H22 N3 O7 P FORMUL 2 26Y C18 H25 N O6 FORMUL 3 HOH *113(H2 O) HELIX 1 1 ILE A 13 GLY A 17 5 5 HELIX 2 2 GLY A 20 THR A 38 1 19 HELIX 3 3 THR A 47 ASP A 78 1 32 HELIX 4 4 THR A 94 ALA A 103 1 10 HELIX 5 5 LEU A 104 LEU A 115 1 12 HELIX 6 6 ASP A 118 GLU A 124 1 7 HELIX 7 7 GLY A 134 LEU A 150 1 17 HELIX 8 8 PRO A 194 THR A 197 5 4 HELIX 9 9 TYR A 262 ASP A 268 1 7 HELIX 10 10 ASP A 268 ASN A 274 1 7 HELIX 11 11 ILE A 275 ARG A 277 5 3 HELIX 12 12 LYS A 289 SER A 313 1 25 HELIX 13 13 ASN A 325 ASP A 327 5 3 HELIX 14 14 ALA A 328 LYS A 332 1 5 HELIX 15 15 LEU A 344 LEU A 356 1 13 HELIX 16 16 ASP A 360 THR A 371 1 12 HELIX 17 17 LEU A 380 LEU A 384 5 5 HELIX 18 18 VAL A 389 LEU A 396 1 8 HELIX 19 19 LEU A 396 PHE A 418 1 23 HELIX 20 20 ASP A 421 SER A 429 1 9 HELIX 21 21 MET A 441 GLY A 448 1 8 HELIX 22 22 ALA A 456 THR A 466 1 11 HELIX 23 23 PHE A 468 GLU A 475 1 8 HELIX 24 24 THR A 487 LEU A 492 1 6 HELIX 25 25 ASN A 496 GLY A 508 1 13 HELIX 26 26 GLU A 509 VAL A 525 5 17 HELIX 27 27 ASP A 527 LYS A 554 1 28 HELIX 28 28 ARG A 575 GLU A 593 1 19 HELIX 29 29 TYR A 613 ASN A 631 1 19 HELIX 30 30 ARG A 649 ILE A 657 1 9 HELIX 31 31 THR A 676 ASN A 684 1 9 HELIX 32 32 ALA A 695 GLY A 704 1 10 HELIX 33 33 GLU A 705 PHE A 708 5 4 HELIX 34 34 ARG A 714 GLY A 725 1 12 HELIX 35 35 ALA A 728 ILE A 735 1 8 HELIX 36 36 ILE A 735 GLY A 748 1 14 HELIX 37 37 PHE A 758 HIS A 768 1 11 HELIX 38 38 LYS A 772 LYS A 792 1 21 HELIX 39 39 ASN A 793 THR A 807 1 15 HELIX 40 40 SER A 808 PHE A 811 5 4 HELIX 41 41 SER A 812 ILE A 824 1 13 SHEET 1 A 3 LYS A 191 ALA A 192 0 SHEET 2 A 3 GLY A 212 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 A 3 LEU A 198 THR A 209 -1 N GLU A 207 O LYS A 214 SHEET 1 B 9 LYS A 191 ALA A 192 0 SHEET 2 B 9 GLY A 212 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 B 9 VAL A 238 LYS A 247 -1 O LYS A 247 N LEU A 222 SHEET 4 B 9 ALA A 154 ILE A 159 1 N GLY A 156 O ARG A 242 SHEET 5 B 9 ARG A 81 LEU A 85 1 N ILE A 82 O TYR A 155 SHEET 6 B 9 VAL A 333 ASN A 338 1 O GLN A 336 N TYR A 83 SHEET 7 B 9 CYS A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 B 9 VAL A 452 GLY A 454 1 O ASN A 453 N TYR A 374 SHEET 9 B 9 PHE A 479 ASN A 481 1 O GLN A 480 N VAL A 452 SHEET 1 C 2 PHE A 89 GLY A 92 0 SHEET 2 C 2 ALA A 129 LEU A 131 -1 O LEU A 131 N PHE A 89 SHEET 1 D 2 ASN A 167 CYS A 171 0 SHEET 2 D 2 TRP A 174 GLU A 178 -1 O MET A 176 N LYS A 169 SHEET 1 E 3 ARG A 386 PRO A 388 0 SHEET 2 E 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 E 3 VAL A 431 GLU A 432 -1 N GLU A 432 O ARG A 438 SHEET 1 F 6 LEU A 640 LEU A 645 0 SHEET 2 F 6 ARG A 601 GLY A 606 1 N VAL A 603 O ARG A 641 SHEET 3 F 6 LEU A 562 VAL A 567 1 N ASP A 564 O MET A 604 SHEET 4 F 6 LEU A 662 GLN A 665 1 O LEU A 662 N VAL A 565 SHEET 5 F 6 LEU A 687 GLY A 690 1 O LEU A 687 N SER A 663 SHEET 6 F 6 PHE A 709 ILE A 710 1 O PHE A 709 N THR A 688 LINK C MET A 679 N LLP A 680 1555 1555 1.33 LINK C LLP A 680 N PHE A 681 1555 1555 1.33 SITE 1 AC1 17 GLY A 135 LEU A 136 ASN A 282 ASP A 283 SITE 2 AC1 17 PHE A 285 HIS A 341 HIS A 377 ASN A 484 SITE 3 AC1 17 TYR A 573 GLU A 672 ALA A 673 SER A 674 SITE 4 AC1 17 GLY A 675 HOH A1060 HOH A1076 HOH A1101 SITE 5 AC1 17 HOH A1108 CRYST1 128.740 128.740 116.710 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007768 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007768 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008568 0.00000